Book a demo
Research & KnowledgeEvent: September 2, 2026

Omada Health published a study in Diabetes, Obesity and Metabolism testing whether virtual, strength-focused activity coaching can shift the balance of weight loss during GLP-1 therapy in 245 adults with obesity.

Published

Signal category

Research & Knowledge

Quote

Our new study in Diabetes, Obesity and Metabolism tested whether virtual, strength-focused activity coaching can shift that balance during GLP-1 therapy

Todd Norwood, PT, DPT, FACHE|Omada Health team

Company

Omada Health

Omada is virtual care that adapts to real life: Obesity, Prediabetes, Diabetes, Heart Health, GLP-1s, Muscle & Joint.

Industry
Hospitals and Health Care
Location
San Francisco, US
Company size
995 employees

For 15 years, Omada Health has been in the corner of millions of Americans managing chronic conditions. We help our members between doctor visits, providing virtual care that adapts to real life. We partner with employers, health plans, pharmacy benefit managers, and government agencies to support their populations across common chronic conditions — from prediabetes, diabetes, and hypertension to muscle and joint pain— all through the convenience of an app. Our programs also adapt to provide specialized care for GLP-1 journeys. At Omada, care isn’t built for perfection. It’s built for real people. Our clinically-validated programs combine human connection with modern technology, pairing members with real coaches and care teams. Omada’s impact is proven: our outcomes are published in 30 peer-reviewed studies, showing lasting behavior change, reduced healthcare costs, and ROI for our partners. Our success starts with our people. Omada’s strong, inclusive culture has earned us the Great Place to Work certification, and in 2025 we became a Nasdaq-listed company — a milestone on our mission to bend the curve of chronic disease.

Founded 2011

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.